When restaurants lobby for “consumer protection” regulations that restrict food trucks, it’s natural to suspect the restaurants are simply trying to use Big Government to crowd out competition.
When H&R Block lobbies for “consumer protection” regulations that crowd out Mom & Pop tax preparers, the anticompetitive.
When liquor stores lobby to keep supermarkets from selling liquor, we don’t assume their main motive is consumer protection.
This month we see the same dynamic in the drugmaking industry, the Washington Post reports: Drug companies are ramping up efforts on Capitol Hill to block specialty pharmacies from mass producing drugs in lightly regulated conditions, urging lawmakers to require that these enterprises return to their traditional roles or face stricter standards.
Commercial drug makers are also pressing a lobbying campaign aimed at stopping these specialty pharmacies, known as compounders, from making “knockoff” drugs for people and their pets that the companies say are costing them millions of dollars in annual profits, records and interviews show.
But the lobbying landscape gets even more interesting, as thePost reports:
Source found hereThe International Academy of Compounding Pharmacists, the industry’s largest trade group,
No comments:
Post a Comment